Seelaus Asset Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
Other funds holding REGN
Seelaus Asset Management's REGN Position: Q2 2026 in Review
Seelaus Asset Management increased its Regeneron Pharmaceuticals (REGN) stake by 41% in Q2 2026, buying an estimated $98.7K and bringing the position to 501 shares worth $312K. The position accounts for 0.22% of the portfolio, ranked #134.
Seelaus Asset Management first reported a position in REGN in Q1 2026 and has held it in 2 quarters since. 1,333 funds tracked by Wall St. Rank hold REGN as of Q2 2026.
- Seelaus Asset Management held 501 shares of Regeneron Pharmaceuticals worth $312K as of Q2 2026.
- Seelaus Asset Management bought 145 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $98.7K.
- Regeneron Pharmaceuticals made up 0.22% of Seelaus Asset Management's portfolio in Q2 2026, its #134 holding.
- Seelaus Asset Management first reported a position in Regeneron Pharmaceuticals in Q1 2026 and has held it in 2 quarters since.
- 1,333 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.
Based on Seelaus Asset Management's 13F filing for Q2 2026, filed 16 Jul 2026.